Johnson & Johnson vs Bio-Techne Corp.
JNJ vs TECH — side-by-side comparison from reported financials. JNJ leads 10, TECH leads 1 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Bio-Techne Corp.
TECH · Healthcare
$72.44-0.01%Strong
| Metric | JNJ | TECH |
|---|---|---|
| Price | $261.79 | $72.44 |
| Market cap | $631B | $11.4B |
| Revenue (TTM) | $97.9B | $1.22B |
| Revenue growth | +5.6% | +2.3% |
| Net margin | 21.5% | 15.0% |
| Free cash flow | $22.2B | $263M |
| Net cash (debt) | ($27.8B) | ($23.6M) |
| 1-year price return | +37.0% | +20.9% |
| P/E | 29.9 | 62.5 |
| P/E vs own history (cheap-side %) | 16% | 14% |
| Dividend yield | 2.00% | 0.44% |
| Return on equity | 26% | 9% |
| Altman Z-score | — | 15.94 |
| CV checks passed | 10 of 11 | 8 of 11 |
| Employees | 140,800 | 3,000 |
Full résumé-style profiles: JNJ CV · TECH CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.